Entity Common Stock, Shares Outstanding of Nuo Therapeutics, Inc. from 31 Jul 2011 to 29 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nuo Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2011 to 29 Oct 2025.
  • Nuo Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 29 Oct 2025 was 48,077,745, a 3.2% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Nuo Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 48,077,745 +1,479,340 +3.2% 29 Oct 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 46,830,788 +1,364,550 +3% 29 Jul 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 46,816,114 +2,574,598 +5.8% 28 Mar 2025 10-K 01 Apr 2025 2024 FY
Q3 2024 46,598,405 +4,281,889 +10% 11 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 45,466,238 +3,149,722 +7.4% 12 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 44,241,516 +2,442,500 +5.8% 15 Apr 2024 10-K 19 Apr 2024 2023 FY
Q3 2023 42,316,516 +517,500 +1.2% 14 Nov 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 42,316,516 +1,234,554 +3% 08 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 41,799,016 +4,674,811 +13% 10 Apr 2023 10-K/A 18 Apr 2023 2022 FY
Q3 2022 41,799,016 03 Nov 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 41,081,962 05 Aug 2022 10-Q/A 10 Aug 2022 2022 Q2
Q1 2022 37,124,205 15 Mar 2022 10-K 15 Apr 2022 2021 FY
Q4 2019 23,722,400 27 Jan 2020 10-Q 31 Jan 2020 2019 Q3
Q2 2019 23,722,400 0 0% 12 Aug 2019 10-Q 19 Aug 2019 2019 Q2
Q1 2019 23,722,400 +1,000,000 +4.4% 31 Mar 2019 10-K 16 Apr 2019 2018 FY
Q3 2018 23,722,400 +995,288 +4.4% 12 Nov 2018 10-Q 16 Nov 2018 2018 Q3
Q2 2018 23,722,400 +4,145,288 +21% 13 Aug 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 22,722,400 +12,795,288 +129% 12 Apr 2018 10-K 16 Apr 2018 2017 FY
Q3 2017 22,727,112 +12,800,000 +129% 07 Nov 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 19,577,112 11 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 9,927,112 24 Mar 2017 10-K 29 Mar 2017 2016 FY
Q3 2016 9,927,112 -115,752,988 -92% 14 Oct 2016 10-Q 24 Oct 2016 2016 Q2
Q3 2015 125,680,100 +1,270,000 +1% 05 Nov 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 125,680,100 +1,270,000 +1% 06 Aug 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 125,680,100 +14,929,023 +13% 20 Mar 2015 10-K 31 Mar 2015 2014 FY
Q3 2014 124,410,100 +19,059,043 +18% 06 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 124,410,100 +19,615,506 +19% 08 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 110,751,077 +6,420,622 +6.2% 10 Mar 2014 10-K 31 Mar 2014 2013 FY
Q3 2013 105,351,057 +13,604,763 +15% 31 Oct 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 104,794,594 +14,099,477 +16% 31 Jul 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 104,330,455 +33,686,428 +48% 04 Mar 2013 10-K 18 Mar 2013 2012 FY
Q3 2012 91,746,294 +38,525,397 +72% 31 Oct 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 90,695,117 +38,549,103 +74% 31 Jul 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 70,644,027 16 Mar 2012 10-K 29 Mar 2012 2011 FY
Q3 2011 53,220,897 04 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 52,146,014 31 Jul 2011 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.